Abstract:Aim: Matrix metalloproteinases can degrade extracellular matrix and basement membrane, so they play important roles in tumor invasion and metastasis. The aim of this study is to study the expression of matrix metalloproteinase 2(MMP-2) and its mRNA in breast carcinoma and tumor cells, and discuss their relationships with tumor biological behavior and angiogenesis. Methods: The experiment was completed in Key Laboratory of Pathobiology, Ministry of Science, School of Basic Medical Sciences, Jilin University from January 2001 to January 2004. The expression of MMP-2, its mRNA and microvessel density(MVD) were detected in 76 cases of breast carcinoma tissues and MCF-7 cells cultured in vitro by immunohistochemistry, immunocytochemistry, in situ hybridization, invasion assay, gelatin zymography and quantitative morphometric analysis. Results: Expression of MMP-2 and its mRNA in breast carcinoma were significantly higher than those in paracancerous normal tissues. MMP-2 and its mRNA were mainly localized in tumor cytoplasm, whose positive rates were 77.63% and 71.05% respectively, and their expressions were both correlated with histological grade and lymph node metastasis of breast carcinoma. MVD in breast carcinoma was closely associated with histological grade and lymph node metastasis. MVD was much higher in the group of MMP-2 and its mRNA with positive expression than in the group of those with negative expression. MMP-2 and its mRNA were positive in MCF-7 cells. MMP-2 antibody could decrease the invasion number of MCF-7 cells from (56.21 ± 3.68) cells per 400 times to (20.32 ± 3.24) cells per 400 times. MCF-7 cells cultivated on the culture flask could secret pro-MMP-2, while on that coated by collagen I could secret more pro-MMP-2 and active MMP-2. Conclusion: Breast carcinoma tissues and cells have stronger ability to secret MMP-2. MMP-2 can promote tumor invasion and metastasis of tumors, and accelerate angiogenesis. Therefore, MMP-2 can be served as a referred indication to determine biological behavior, clinical therapy and prognosis of breast carcinoma.

Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro

Inhibition of Ameloblastoma Invasion in Vitro and in Vivo by Inhibitor of Metalloproteinase-2 Activity.

Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.

Relationship Between Activity of Matrix Metalloproteinase-2 and Invasiveness in Ameloblastoma

The expression of BMP-2 mRNA in ameloblastoma of the jaw bone

Effects of Matrix Metalloproteinase-2 Inhibitor on the Invasion of Ameloblastoma Cells in Vitro

Association of Matrix Metalloproteinase-2 Activity with Cell Proliferation and Growth in Ameloblastoma

Inhibition against xenografts of ameloblastoma in nude mice using MMP-2 targeting siRNA

THE EXPRESSION AND SIGNIFICANCE OF MATRIX METALLOPROTEINASE-2(MMP-2) IN AMELOBLASTOMA

The Role of RANKL and MMP-9 in the Bone Resorption Caused by Ameloblastoma

Expression of matrix metalloproteinase and collagen type Ⅳ in ameloblastoma

The Effect of MMP-2 Inhibitor 1 on Osteogenesis and Angiogenesis During Bone Regeneration.

Inhibition of Invasiveness of Pancreatic Carcinoma Cell Line PANC-1 by Suppression of MMP-2 Gene Expression Using RNA Interference

[Suppression to ameloblastoma xenografts of chicken embryo chorioallantoic membrane by tissue inhibitor of metalloproteinases-2]

Molecular Markers of Tumor Invasiveness in Ameloblastoma: an Update.

The Expression and Significance of RANKL,MMP-9 and MMP-2 in Ameloblastoma

RECK overexpression reduces invasive ability in ameloblastoma cells.

ERK-mediated upregulation of matrix metalloproteinase-2 promotes the invasiveness in human oral squamous cell carcinoma (OSCC)

Relationship of matrix metalloproteinase 2 with angiogenesis and biological behavior in breast carcinoma

METTL1 facilitates ameloblastoma invasive growth via MAPK signaling pathway

MMP13 Expression and Activity Suggest Its Role in Bone Resorption in Ameloblastomas